Therefore, this is the first description of S1PRs in leukocytes with significant differences among BC patients without and with chemotherapy (BCC), which opens new avenues for investigation of drug targets, mainly by observing the variation of S1PR1 and S1PR4. This evidence concerns the gene S1PR1 and breast cancer.